Poly-resistant Tuberculosis in an HIV-infected Child

Area of Science:

• Pediatrics
• Infectious Diseases
• Public Health

Background:

• Drug-resistant tuberculosis (DR-TB) poses a significant global health challenge, further complicated by HIV co-infection.
• Tuberculosis (TB) treatment in HIV-infected individuals requires careful management due to potential drug interactions.
• DR-TB is infrequently documented in pediatric populations, especially in resource-limited settings like India.

Observation:

• This report details a rare case of poly-resistant tuberculosis (resistance to Streptomycin and Isoniazid) in an HIV-infected child.
• The child developed poly-resistant TB three years after completing a full course of anti-tuberculosis treatment (ATT).
• Notably, the child's mother had also received ATT three years prior, suggesting a potential transmission or re-exposure risk.

Findings:

• Poly-resistant TB is exceptionally uncommon in children, particularly those who are HIV-positive.
• Prior anti-tuberculosis treatment and contact with adults on second-line ATT are critical factors to consider in diagnosing DR-TB in HIV-infected children.
• This case underscores the challenges in managing TB in immunocompromised children with complex resistance patterns.

Implications:

• Healthcare providers should maintain a high index of suspicion for DR-TB in HIV-infected children with a history of prior ATT or exposure to adults on second-line therapy.
• Early diagnosis and appropriate management of DR-TB in children are crucial to improve treatment outcomes and prevent transmission.
• Further research is needed to understand the epidemiology and optimal treatment strategies for DR-TB in pediatric populations, especially in the context of HIV co-infection.